Final diagnosis
| Diagnosis | Patient numbre | % |
| NSCLC ADK | 113 | 39.2 |
| Breast cancer | 62 | 21.5 |
| NSCLC squamous | 19 | 6.5 |
| Unknown | 13 | 4.5 |
| SCLC | 12 | 4.1 |
| Melanoma | 10 | 3.5 |
| ADK of undetermined origin | 10 | 3.5 |
| NSCLC non differentiated | 7 | 2.4 |
| Lymphoma | 6 | 2 |
| Ovary | 6 | 2 |
| Kidney | 5 | 1.7 |
| Head-Neck | 3 | 1 |
| Sarcoma | 3 | 1 |
| Stomach | 3 | 1 |
| Bladder | 2 | 0.7 |
| Colon | 2 | 0.7 |
| LCLC | 2 | 0.7 |
| Oesophagus | 2 | 0.7 |
| Prostate | 2 | 0.7 |
| Endometrial | 1 | 0.3 |
| Hodgkin | 1 | 0.3 |
| Pancreas | 1 | 0.3 |
| Synovialosarcoma | 1 | 0.3 |
| Thyroid | 1 | 0.3 |
| Uvea | 1 | 0.3 |
NSCLC = non small cell lung cancer, ADK = adenocarcinoma, SCLC = small cell lung cancer, LCLC = large cell lung cancer